Jacques Noel

Title: Jacques Noel: Innovator in Pain Management

Introduction

Jacques Noel is a notable inventor based in Nice, France. He has made significant contributions to the field of pain management through his innovative research and development of peptide toxins.

Latest Patents

Jacques Noel holds a patent for a method of treating pain or itching with the APETx2 peptide toxin. This invention relates to the use of the peptide toxin APETx2, which blocks the ASIC3 cationic channels and is derived from the sea anemone. The patent focuses on the application of this peptide as a drug, particularly as an analgesic for pain associated with the activation of ASIC3 channels. This includes pain that occurs during inflammation and other painful situations linked to tissue acidosis, such as ischemia, fractures, hematomas, edema, local infections, tissue lesions, ocular wounds, and tumors. He has 1 patent to his name.

Career Highlights

Throughout his career, Jacques Noel has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Nice Sophia Antipolis. His work has been pivotal in advancing the understanding and treatment of pain.

Collaborations

Jacques has collaborated with notable scientists, including Michel Lazdunski and Éric Lingueglia, enhancing the impact of his research through shared expertise.

Conclusion

Jacques Noel's innovative work in the field of pain management exemplifies the importance of research and development in creating effective treatments. His contributions continue to influence the medical community and improve patient care.